Research on diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection
Tang Guo-chua
Abstract
Tang Guo-chua
Abstract
Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group(n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed.Results The curative rate in treatment group was higher than control group([80.00%,n=24]vs[53.33%,n=16])(χ2=4.80,P=0.028).The incidence of RUTI in treatment group was lower than control group([6.67%,n=2]vs[26.67%,n=8])(χ2=4.32,P=0.038).Incidence of adverse reactions in treatment group was lower than control group(16.67% vs 50.00%)(χ2=7.50,P=0.006).Conclusion The diminishing scheme of cefaclor sustained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reactions,and can be used for the treatment of recurrence of RUTI.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the efficacy and adverse reactions of diminishing scheme of cefaclor sustained release tablets in the treatment of recurrent urinary tract infection(RUTI).Methods 60 RUTI patients in a hospital were divided into treatment group(n=30)and control group(n=30),patients in treatment group were treated with diminishing scheme of cefaclor sustained release tablets,patients in control group were treated with diminishing scheme of levofloxacin tablets,clinical therapeutic efficacy and adverse reactions of two groups were observed.Results The curative rate in treatment group was higher than control group([80.00%,n=24]vs[53.33%,n=16])(χ2=4.80,P=0.028).The incidence of RUTI in treatment group was lower than control group([6.67%,n=2]vs[26.67%,n=8])(χ2=4.32,P=0.038).Incidence of adverse reactions in treatment group was lower than control group(16.67% vs 50.00%)(χ2=7.50,P=0.006).Conclusion The diminishing scheme of cefaclor sustained release tablets in the treatment of RUTI has good curative efficacy,low recurrence rate,fewer adverse reactions,and can be used for the treatment of recurrence of RUTI.
Key concepts: Cefaclor, Medicine, Adverse effect, Urinary system, Incidence (geometry), Internal medicine, Clinical efficacy, Gastroenterology